Clínica Baviera, S.A. (BME: CBAV)
Spain
· Delayed Price · Currency is EUR 34.80
-0.20 (-0.57%)
Nov 22, 2024, 5:35 PM CET
Clínica Baviera Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 38.41 | 35.97 | 29.52 | 27.39 | 13.94 | 12.79 | Upgrade
|
| Depreciation & Amortization | 18.04 | 16.46 | 14.8 | 13.89 | 13.38 | 13.02 | Upgrade
|
| Other Amortization | 0.52 | 0.52 | 0.2 | 0.2 | 0.16 | 0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.47 | 0.03 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.02 | -0.02 | 0.18 | 0.06 | 0.01 | 0 | Upgrade
|
| Other Operating Activities | 4.73 | 3.09 | 3.25 | 1.44 | 1.56 | 1.5 | Upgrade
|
| Change in Accounts Receivable | -0.43 | -0.43 | 0.18 | -0.91 | 0.56 | -1.57 | Upgrade
|
| Change in Inventory | -0.31 | -0.31 | -0.23 | -0.29 | -0.44 | -0.14 | Upgrade
|
| Change in Accounts Payable | 2.5 | 2.5 | 5.02 | 5.04 | 2.29 | -0.41 | Upgrade
|
| Operating Cash Flow | 66.5 | 57.81 | 53.38 | 46.86 | 31.46 | 25.4 | Upgrade
|
| Operating Cash Flow Growth | 24.10% | 8.31% | 13.92% | 48.96% | 23.83% | 51.08% | Upgrade
|
| Capital Expenditures | -27.44 | -22.68 | -14.03 | -10.58 | -7.82 | -9.19 | Upgrade
|
| Cash Acquisitions | - | - | - | -0.05 | - | -0.91 | Upgrade
|
| Investment in Securities | -35.67 | -21.79 | 1.4 | -6.46 | -13.59 | 3.42 | Upgrade
|
| Other Investing Activities | 13.68 | 0.15 | 0.07 | 0 | 0.01 | 0 | Upgrade
|
| Investing Cash Flow | -49.43 | -44.31 | -12.56 | -17.08 | -21.4 | -6.68 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.08 | 10.04 | 5.19 | Upgrade
|
| Long-Term Debt Repaid | - | -10.52 | -13.69 | -13.43 | -12.93 | -13.97 | Upgrade
|
| Net Debt Issued (Repaid) | -10.53 | -10.52 | -13.69 | -13.35 | -2.89 | -8.78 | Upgrade
|
| Issuance of Common Stock | 0.61 | 0.71 | 0.6 | 0.5 | 0.2 | 0.14 | Upgrade
|
| Repurchase of Common Stock | -9.75 | -0.71 | -0.62 | -0.49 | -0.19 | -0.21 | Upgrade
|
| Common Dividends Paid | - | -13.04 | -16.79 | -17.15 | - | -9.46 | Upgrade
|
| Other Financing Activities | -1.35 | -0.81 | -0.95 | -0.31 | -0.27 | -0.4 | Upgrade
|
| Financing Cash Flow | -21.02 | -24.37 | -31.45 | -30.8 | -3.15 | -18.71 | Upgrade
|
| Net Cash Flow | -3.95 | -10.87 | 9.37 | -1.02 | 6.9 | 0.01 | Upgrade
|
| Free Cash Flow | 39.06 | 35.13 | 39.35 | 36.28 | 23.64 | 16.21 | Upgrade
|
| Free Cash Flow Growth | 9.13% | -10.71% | 8.45% | 53.49% | 45.81% | 112.26% | Upgrade
|
| Free Cash Flow Margin | 16.05% | 15.47% | 19.83% | 20.94% | 19.28% | 13.04% | Upgrade
|
| Free Cash Flow Per Share | 2.40 | 2.16 | 2.41 | 2.23 | 1.45 | 0.99 | Upgrade
|
| Cash Interest Paid | 0.72 | 0.11 | 0.46 | 0.11 | 0.12 | 0.07 | Upgrade
|
| Cash Income Tax Paid | 11.56 | 11.64 | 9.63 | 11.28 | 4.36 | 4.07 | Upgrade
|
| Levered Free Cash Flow | 61.55 | 26.81 | 33.33 | 31.68 | 21.5 | 16.38 | Upgrade
|
| Unlevered Free Cash Flow | 61.94 | 27.16 | 33.59 | 31.96 | 21.84 | 16.75 | Upgrade
|
| Change in Net Working Capital | -37.66 | -1.59 | -6.4 | -3.78 | -3.72 | -1.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.